Agilent Technologies, Inc. A NYSE

Agilent Technologies, Inc. (A) reported total assets of $12.73B and total liabilities of $5.99B for fiscal year 2025, resulting in total equity of $6.74B.

The company held $1.79B in cash and short-term investments. Total debt stood at $3.35B, with net debt of $1.57B. The Debt-to-Equity (D/E) ratio was 0.5 (moderate).

Current ratio is 1.96, indicating strong short-term liquidity. Interest coverage is 13.2x (strong).

Criteria supported by this page:

• HEALTH (83/100, Pass) — Debt-to-Equity of 0.5, current ratio of 1.96, interest coverage 13.2x — balance sheet is strong
• MOAT (76/100) — Total assets $12.73B and equity $6.74B support the company's competitive scale
• VALUE (58/100) — Debt-to-Equity 0.5 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 74/100 with 5/7 criteria passed.

TMO

Thermo Fisher Scientific Inc.

$527.22

+2.53%

DHR

Danaher Corporation

$198.61

+1.40%

BDX

Becton, Dickinson and Company

$155.73

+0.19%

CAH

Cardinal Health, Inc.

$214.95

+0.36%

IDXX

IDEXX Laboratories, Inc.

$584.05

+1.75%

EW

Edwards Lifesciences Corporation

$78.20

+0.10%

HLN

Haleon plc

$9.70

-1.32%

ALC

Alcon Inc.

$79.94

+0.25%